JPY 1487.0
(-1.98%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 15.42 Billion | 354 Million | -12.76 Billion | 739 Million | 11.09 Billion | 17.96 Billion |
Net Income | 2.3 Billion | 2.07 Billion | -8.56 Billion | -2.65 Billion | 3.24 Billion | 565 Million |
Depreciation & Amortization | 3.19 Billion | 3.56 Billion | 3.2 Billion | 3.14 Billion | 3.15 Billion | 4.4 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 9.7 Billion | -8.31 Billion | -10.1 Billion | -1.49 Billion | 7.38 Billion | 11.31 Billion |
Other non-cash items | -88 Million | 3.02 Billion | 2.69 Billion | 1.74 Billion | -2.7 Billion | 1.67 Billion |
Investing Cash Flow | -8.53 Billion | -1.32 Billion | -3.07 Billion | -1.96 Billion | 516 Million | -3.42 Billion |
Investments in PPE | -4.93 Billion | -2.55 Billion | -2.74 Billion | -2.13 Billion | -4.32 Billion | -3.99 Billion |
Acquisitions | 327 Million | 201 Million | -91 Million | -31 Million | 2.77 Billion | 459 Million |
Investment purchases | -3.92 Billion | -201 Million | -1.55 Billion | -771 Million | -1.5 Billion | -2.76 Billion |
Sales/Maturities of investments | - | 1.15 Billion | 1.19 Billion | 990 Million | 3.35 Billion | 2.96 Billion |
Other Investing Activities | 3 Million | 85 Million | 123 Million | -18 Million | 221 Million | -92 Million |
Financing Cash Flow | -4.44 Billion | 1.77 Billion | 6.77 Billion | -2.62 Billion | -8.82 Billion | -2.93 Billion |
Debt repayment | -3.47 Billion | -818 Million | -1.54 Billion | -1.75 Billion | -7.53 Billion | -1.71 Billion |
Dividends payments | -447 Million | -223 Million | -335 Million | -570 Million | -681 Million | -1.15 Billion |
Common Stock Repurchased | - | - | -48 Million | -569 Million | - | -4.5 Billion |
Common Stock Issuance | - | - | 8.69 Billion | 269 Million | - | 4.43 Billion |
Other Financing Activities | -516 Million | 2.81 Billion | -1 Million | -1 Million | -604 Million | -1 Million |
Accounts receivables | 478 Million | -4.97 Billion | -1.51 Billion | -1.63 Billion | 3.68 Billion | 2.7 Billion |
Accounts payables | 1.99 Billion | -2.69 Billion | 1.81 Billion | 1.33 Billion | -723 Million | -4.98 Billion |
Inventory | 4.23 Billion | 2.55 Billion | -10.25 Billion | -792 Million | 4.74 Billion | 14.27 Billion |
Other working capital | 3.01 Billion | -3.2 Billion | -148 Million | -401 Million | -320 Million | -678 Million |
Cash at beginning of period | 13.64 Billion | 12.08 Billion | 20.37 Billion | 23.93 Billion | 21.52 Billion | 10.15 Billion |
Cash at end of period | 17.03 Billion | 13.64 Billion | 12.08 Billion | 20.37 Billion | 23.93 Billion | 21.52 Billion |
Capital Expenditure | -4.93 Billion | -2.55 Billion | -2.74 Billion | -2.13 Billion | -4.32 Billion | -3.99 Billion |
Effect of forex changes on cash | 938 Million | 747 Million | 782 Million | 287 Million | -378 Million | -224 Million |
Net cash flow / Change in cash | 3.38 Billion | 1.55 Billion | -8.28 Billion | -3.55 Billion | 2.4 Billion | 11.37 Billion |
Free Cash Flow | 10.48 Billion | -2.2 Billion | -15.51 Billion | -1.39 Billion | 6.76 Billion | 13.96 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.1 Billion | -175 Million | 2.3 Billion | 1.36 Billion | 1.63 Billion | 509 Million |
Depreciation & Amortization | 819 Million | 844 Million | 3.19 Billion | 830 Million | 792 Million | 731 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.16 Billion | 2.21 Billion | 9.7 Billion | -173 Million | 2.86 Billion | 4.72 Billion |
Other non-cash items | -1.1 Billion | 200 Million | -88 Million | -470 Million | 271 Million | -628 Million |
Investing Cash Flow | -451 Million | -4.42 Billion | -8.53 Billion | -2.77 Billion | -800 Million | -537 Million |
Investments in PPE | -1.09 Billion | -836 Million | -4.93 Billion | -2.73 Billion | -745 Million | -584 Million |
Acquisitions | - | -3 Million | 327 Million | 330 Million | - | - |
Investment purchases | - | -3.57 Billion | -3.92 Billion | -356 Million | - | - |
Sales/Maturities of investments | 660 Million | - | - | 1 Million | - | - |
Other Investing Activities | 647 Million | -13 Million | 3 Million | -14 Million | -55 Million | 47 Million |
Financing Cash Flow | -1.89 Billion | -753 Million | -4.44 Billion | 3.5 Billion | -4.6 Billion | -2.58 Billion |
Debt repayment | -1.25 Billion | -582 Million | -3.47 Billion | -3.84 Billion | -150 Million | -150 Million |
Dividends payments | -336 Million | - | -447 Million | -224 Million | - | -223 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -297 Million | -170 Million | -516 Million | 7.56 Billion | -4.45 Billion | -2.21 Billion |
Accounts receivables | -1.1 Billion | -650 Million | 478 Million | 673 Million | -668 Million | 1.56 Billion |
Accounts payables | 1.73 Billion | -809 Million | 1.99 Billion | 1.22 Billion | 1.3 Billion | 273 Million |
Inventory | -865 Million | 3.05 Billion | 4.23 Billion | -2.27 Billion | 881 Million | 2.56 Billion |
Other working capital | -928 Million | 613 Million | 3.01 Billion | 202 Million | 1.34 Billion | 314 Million |
Cash at beginning of period | 17.03 Billion | 18.86 Billion | 13.64 Billion | 16.88 Billion | 16.21 Billion | 13.64 Billion |
Cash at end of period | 19.7 Billion | 17.03 Billion | 17.03 Billion | 18.86 Billion | 16.88 Billion | 16.21 Billion |
Capital Expenditure | -1.09 Billion | -836 Million | -4.93 Billion | -2.73 Billion | -745 Million | -584 Million |
Effect of forex changes on cash | - | 357 Million | 938 Million | -293 Million | 516 Million | 358 Million |
Net cash flow / Change in cash | 2.67 Billion | -1.83 Billion | 3.38 Billion | 1.98 Billion | 664 Million | 2.57 Billion |
Free Cash Flow | -81 Million | 2.15 Billion | 10.48 Billion | -1.18 Billion | 4.8 Billion | 4.75 Billion |
4534
RHIM
EDTXF
ACBM
ALIT
RCM